Delivery Order 47QTCB22D0589-75F40125F80116

Award Date 7/16/25
Potential Completion Date 1/20/27
Potential Value $3.5M
Awardee
Agisol LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including...
The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
The U.S. Food and Drug Administration (FDA) awarded a 2-year, $4,499,944.46 Firm Fixed Price (FFP) purchase order to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to provide business process user support for the Center for Drug Evaluation and Research (CDER). This contract, which is not set aside, supports critical regulatory review and drug safety activities within CDER. Agisol LLC is a specialized IT services provider that has secured...
This is a sole source 8(a) set-aside federal contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business. The contract is for $597,096.99 and provides process documentation and development services to the FDA's Center for Drug Evaluation and Research (CDER). The contract has a period of performance through August 21, 2028. Agisol LLC, a certified 8(a) program participant, is the prime contractor for this contract. The company...
The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...
The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a one-year, $1.5 million firm fixed price delivery order contract to Agisol LLC. The contract is for CDER Regulatory Review Systems and Data Support under the Multiple Award Schedule contract vehicle. As the prime, Agisol will provide information technology services and solutions to support HHS FDA's Center for Drug Evaluation and Research programs. No subcontractors or set aside designations were...
This is a $1,960,158.65 delivery order awarded by the Food and Drug Administration (FDA) to Agilistek LLC, an 8(a) certified small disadvantaged business, for the FDA Foreign Inspection Planning and Scheduling System (FIPSS) Phase 4 project. The purpose of this modification is to de-obligate funds and close out the contract. Agilistek, a minority-owned IT services firm, has secured multiple contracts with the FDA to develop, enhance, and maintain the FIPSS system, which supports critical...

This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business based in Marriottsville, Maryland. The contract, valued at $3,508,732.19, is for regulatory review systems analysis and sunset support services for the Center for Drug Evaluation and Research (CDER). The contract has no set-aside designation and is set to be completed by January 20, 2027.

Agisol LLC holds an 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services administered by the General Services Administration (GSA). The company also maintains a GSA Multiple Award Schedule (MAS) contract, through which it has received additional delivery orders for regulatory review systems and process documentation services supporting the FDA's complex regulatory and technological needs.

Generated 7/17/25, 2:12 PM